Could Patients’ Own Bone Marrow Hold the Key to Diabetes Treatment?

In a groundbreaking study, researchers are now exploring the potential of using a patient’s own bone marrow-derived stem cells to provide stem cell therapy for managing diabetes – essentially harnessing the body’s own power! 💪

Experts including Prof. Dato’ Sri Dr. Mike Chan and Prof. Dato’ Sri Dr. Michelle Wong summarized their exciting findings in a research article published in the American Journal of Medical & Clinical Research & Reviews.

Here are some key insights…

✅ A Safer Approach: Could using a patient’s own bone marrow stem cells (autologous BMMNCs) offer a potentially safer route for diabetes therapy by minimizing risks seen with donor cells?

✅Potential for Better Control: Clinical studies suggest autologous BMMNC infusion holds promise for improving blood sugar levels (HbA1c) and possibly reducing insulin needs in Type 1 & Type 2 Diabetes.

✅ Hope for Patients with Complications: This therapy shows potential for addressing difficult diabetes-related issues e.g. conditions like kidney problems (nephropathy) or non-healing foot ulcers.

Watch the video:
https://youtube.com/shorts/ulJ6z7PB7Po

Explore their findings in the full article: https://european-wellness.eu/publications/clinical-safety-and-therapeutic-efficacy-of-autologous-bone-marrow/

More EW Publications: https://european-wellness.eu/publications/